A Cellular Deficiency of Gangliosides Causes Hypersensitivity to Clostridium perfringens Phospholipase C*
暂无分享,去创建一个
Yoshio Hirabayashi | J. Gutiérrez | B. Catimel | Y. Hirabayashi | E. Nice | M. Flores-Díaz | A. Alape-Girón | R. Titball | M. Thelestam | Bruno Catimel | Alberto Alape-Girón | Marietta Flores-Díaz | G. Clark | Graeme Clark | Ed Nice | José-María Gutiérrez | Richard Titball | Monica Thelestam | M. Flores-Dı́az
[1] W. Liu,et al. Wheat germ lectin induces G2/M arrest in mouse L929 fibroblasts , 2004, Journal of cellular biochemistry.
[2] G. Schwarzmann,et al. Uptake and metabolism of exogenous glycosphingolipids by cultured cells. , 2001, Seminars in cell & developmental biology.
[3] B. Maggio,et al. The surface behavior of glycosphingolipids in biomembranes: a new frontier of molecular ecology. , 1994, Progress in biophysics and molecular biology.
[4] J. Rood. Virulence genes of Clostridium perfringens. , 1998, Annual review of microbiology.
[5] B. Persson,et al. Cellular UDP-Glucose Deficiency Caused by a Single Point Mutation in the UDP-Glucose Pyrophosphorylase Gene* , 1997, The Journal of Biological Chemistry.
[6] C. Kent,et al. Regulation of phosphatidylcholine biosynthesis in mammalian cells. I. Effects of phospholipase C treatment on phosphatidylcholine metabolism in Chinese hamster ovary cells and LM mouse fibroblasts. , 1983, The Journal of biological chemistry.
[7] I. Bianco,et al. Effect of sulfatide and gangliosides on phospholipase C and phospholipase A2 activity. A monolayer study. , 1990, Biochimica et biophysica acta.
[8] B. Lomonte,et al. Broad cytolytic specificity of myotoxin II, a lysine-49 phospholipase A2 of Bothrops asper snake venom. , 1994, Toxicon : official journal of the International Society on Toxinology.
[9] Claudio Cobelli,et al. Roles of Glucose Transport and Glucose Phosphorylation in Muscle Insulin Resistance of NIDDM , 1996, Diabetes.
[10] D. Stevens,et al. The pathogenesis of clostridial myonecrosis. , 2000, International journal of medical microbiology : IJMM.
[11] K. Prydz,et al. Synthesis and sorting of proteoglycans. , 2000, Journal of cell science.
[12] P. Roggentin,et al. Diversity in the properties of two sialidase isoenzymes produced by Clostridium perfringens spp. , 1995, Biological chemistry Hoppe-Seyler.
[13] J. Vázquez-Boland,et al. The Comprehensive Sourcebook of Bacterial Protein Toxins , 2006 .
[14] M. Burke,et al. Nontraumatic clostridial myonecrosis. , 1999, The American journal of forensic medicine and pathology.
[15] S. Sprang,et al. Structure of the protein kinase Cbeta phospholipid-binding C2 domain complexed with Ca2+. , 1998, Structure.
[16] P. Roggentin,et al. The sialidase gene from Clostridium septicum: cloning, sequencing, expression in Escherichia coli and identification of conserved sequences in sialidases and other proteins , 1991, Molecular and General Genetics MGG.
[17] J. M. Gutierrez,et al. Identification of residues critical for toxicity in Clostridium perfringens phospholipase C, the key toxin in gas gangrene. , 2000, European journal of biochemistry.
[18] H. Rasmussen,et al. Regulation of protein kinase C activity by gangliosides. , 1987, The Journal of biological chemistry.
[19] R. Titball,et al. Differences in the Carboxy-Terminal (Putative Phospholipid Binding) Domains of Clostridium perfringens andClostridium bifermentans Phospholipases C Influence the Hemolytic and Lethal Properties of These Enzymes , 1999, Infection and Immunity.
[20] I. Florin. Isolation of a fibroblast mutant resistant to Clostridium difficile toxins A and B. , 1991, Microbial pathogenesis.
[21] K. Sandhoff,et al. Tunicamycin inhibits ganglioside biosynthesis in rat liver Golgi apparatus by blocking sugar nucleotide transport across the membrane vesicles. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[22] D. Moss,et al. Identification of residues in the carboxy-terminal domain of Clostridium perfringens alpha-toxin (phospholipase C) which are required for its biological activities. , 2000, Archives of biochemistry and biophysics.
[23] David S Moss,et al. Crystal structure of the C. perfringens alpha-toxin with the active site closed by a flexible loop region. , 2002, Journal of molecular biology.
[24] E. Heinz,et al. In vitro characterization of anti-glucosylceramide rabbit antisera. , 2000, Glycobiology.
[25] E. Berger,et al. Golgi-disturbing agents , 1998, Histochemistry and Cell Biology.
[26] Shinichi Nakamura,et al. Clostridium absonum alpha-toxin: new insights into clostridial phospholipase C substrate binding and specificity. , 2003, Journal of molecular biology.
[27] A. Elbein. Glycosidase inhibitors: inhibitors of N‐linked oligosaccharide processing , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] Y. Hirabayashi,et al. Glucosylceramide synthase and glycosphingolipid synthesis. , 1998, Trends in cell biology.
[29] G. Zimmerman,et al. Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. , 1997, The Journal of clinical investigation.
[30] Hui Zhao,et al. Anoxia and reoxygenation of human endothelial cells decreases ceramide glucosyltransferase expression and activates caspases , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] M. Nagahama,et al. Membrane-damaging action of Clostridium perfringens alpha-toxin on phospholipid liposomes. , 1996, Biochimica et biophysica acta.
[32] M. Čačić,et al. Glycosphingolipid expression in human skeletal and heart muscle assessed by immunostaining thin-layer chromatography , 2004, Glycoconjugate Journal.
[33] R. Titball,et al. The Clostridium perfringensα-toxin , 1999 .
[34] M. Flores-Díaz,et al. Tyrosine 331 and phenylalanine 334 in Clostridium perfringens α‐toxin are essential for cytotoxic activity , 2001, FEBS letters.
[35] R. Schnaar,et al. High‐Affinity Anti‐Ganglioside IgG Antibodies Raised in Complex Ganglioside Knockout Mice , 2000, Journal of neurochemistry.
[36] E C Nice,et al. Direct immobilization of gangliosides onto gold-carboxymethyldextran sensor surfaces by hydrophobic interaction: applications to antibody characterization. , 1998, Glycobiology.
[37] U. Neumann,et al. Glycosphingolipids of skeletal muscle: I. Subcellular distribution of neutral glycosphingolipids and gangliosides in rabbit skeletal muscle. , 1998, Carbohydrate research.
[38] P. Roggentin,et al. Sialidase activity in the sera of patients and rabbits with clostridial myonecrosis. , 1985, Clinica chimica acta; international journal of clinical chemistry.
[39] F. Goñi,et al. Dual inhibitory effect of gangliosides on phospholipase C-promoted fusion of lipidic vesicles. , 1996, Biochemistry.
[40] M. Jensen,et al. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. , 2000, Diabetes.
[41] D. Moss,et al. Structure of the key toxin in gas gangrene , 1998, Nature Structural &Molecular Biology.
[42] F. Goñi,et al. Inhibition by gangliosides of Bacillus cereus phospholipase C activity against monolayers, micelles and bilayer vesicles. , 1996, European journal of biochemistry.
[43] Thilo Stehle,et al. Gangliosides are receptors for murine polyoma virus and SV40 , 2003, The EMBO journal.
[44] Wesley E. Martin,et al. A novel class of microbial phosphocholine‐specific phospholipases C , 2002, Molecular microbiology.
[45] Alfred H. Merrill,et al. De Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway* , 2002, The Journal of Biological Chemistry.
[46] S. Cole,et al. UDP-glucose Deficiency Causes Hypersensitivity to the Cytotoxic Effect of Clostridium perfringens Phospholipase C* , 1998, Journal of Biological Chemistry.
[47] Y. Hirabayashi,et al. Complete Removal of Sphingolipids from the Plasma Membrane Disrupts Cell to Substratum Adhesion of Mouse Melanoma Cells* , 1996, The Journal of Biological Chemistry.
[48] G. Tettamanti. Ganglioside/glycosphingolipid turnover: New concepts , 2003, Glycoconjugate Journal.
[49] P. Roggentin,et al. Gene structure of the ‘large’ sialidase isoenzyme fromClostridium perfringens A99 and its relationship with other clostridialnanH proteins , 1994, Glycoconjugate Journal.
[50] M. Hattori,et al. Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[51] R. Titball,et al. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene. , 1993, Vaccine.
[52] W. Goebel,et al. Listeria Pathogenesis and Molecular Virulence Determinants , 2001, Clinical Microbiology Reviews.
[53] J. Esko,et al. Chinese Hamster Ovary Cell Mutants Defective in Glycosaminoglycan Assembly and Glucuronosyltransferase I* , 1999, The Journal of Biological Chemistry.
[54] D. Court,et al. Transcription antitermination: the λ paradigm updated , 1995 .
[55] M. Flores-Díaz,et al. Effects of Clostridium perfringens phospholipase C in mammalian cells. , 2004, Anaerobe.
[56] S. Hakomori,et al. An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo. , 1988, Cancer research.
[57] A. Helenius,et al. Intracellular functions of N-linked glycans. , 2001, Science.
[58] R. Schnaar,et al. Tunicamycin inhibits ganglioside biosynthesis in neuronal cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[59] T. Karasawa,et al. Clostridium sordellii Phospholipase C: Gene Cloning and Comparison of Enzymatic and Biological Activities with Those of Clostridium perfringens and Clostridium bifermentans Phospholipase C , 2003, Infection and Immunity.
[60] J. Songer,et al. Bacterial phospholipases and their role in virulence. , 1997, Trends in microbiology.